Current Opinion in Behavioral Sciences,
Год журнала:
2024,
Номер
59, С. 101442 - 101442
Опубликована: Авг. 30, 2024
With
the
expanding
legalization
and
decriminalization,
cannabis
price
has
decreased,
its
use
increased
along
with
content
of
main
ingredient,
THC.
Although
prevalence
rates
for
consumption
during
adolescence
appear
unchanged,
more
potent
availability
powerful
synthetic
cannabinoids
have
enhanced
health
risks
associated
use.
The
pregnancy
also
risen
because
availability/acceptability
misconception
that
is
safe.
Evidence
shows
development
cognitive
deficits
mental
illnesses.
Particularly,
exposure
to
in
utero
or
derails
normal
dopamine
system
produces
aberrant
behaviors.
In
this
review,
we
discuss
long-term
impact
THC
on
behaviors
related
mesolimbic
function,
highlight
areas
research
deserve
investigation
future.
Schizophrenia Bulletin Open,
Год журнала:
2024,
Номер
5(1)
Опубликована: Янв. 1, 2024
Abstract
Cognitive
Impairment
Associated
with
Schizophrenia
(CIAS)
represents
one
of
the
core
dimensions
Spectrum
Disorders
(SSD),
an
important
negative
impact
on
real-world
functional
outcomes
people
living
SSD.
Treatment
CIAS
a
therapeutic
goal
considerable
importance,
and
while
cognition-oriented
evidence-based
psychosocial
interventions
are
available,
effective
pharmacological
treatment
could
represent
game-changer
in
lives
The
present
critical
review
reports
discusses
evidence
regarding
effects
several
agents
that
available
clinical
practice
or
under
study,
commenting
both
current
future
perspectives
treatment.
In
particular,
antipsychotic
medications,
anticholinergic
benzodiazepines,
which
currently
commonly
used
SSD,
iclepertin,
d-serine,
luvadaxistat,
xanomeline-trospium,
ulotaront,
anti-inflammatory
molecules,
oxytocin,
undergoing
regulatory
trials
can
be
considered
as
experimental
agents,
will
reported
discussed.
Currently,
do
not
appear
to
provide
substantial
benefits
CIAS,
but
accurate
management
medications
avoiding
treatments
further
exacerbate
strategies.
Some
molecules
being
investigated
Phase
2
3
have
provided
very
promising
preliminary
results,
more
information
is
required
assess
their
effectiveness
contexts
clear
recommendations
use
practice.
results
ongoing
studies
reveal
whether
any
these
awaited
CIAS.
Acceptance
and
Commitment
Therapy
(ACT)
is
a
third-wave
cognitive-behavioral
therapy
which
focuses
on
acceptance,
mindfulness
values-based
actions
to
support
living
rich
meaningful
life.
ACT
has
been
successfully
applied
recovery
from
psychosis
across
multiple
contexts.
This
paper
provides
an
overview
of
for
psychosis,
followed
by
outline
how
effectively
adapt
individuals
experiencing
including
various
practical
clinical
tips
practitioners.
Finally,
the
research
literature
supporting
efficacy
presented,
consideration
next
steps
in
innovations.
Brain Sciences,
Год журнала:
2025,
Номер
15(2), С. 169 - 169
Опубликована: Фев. 9, 2025
Cerebral
lateralisation
is
a
core
organising
principle
of
the
brain
that
characterised
by
complex
pattern
hemispheric
specialisations
and
interhemispheric
interactions.
In
various
mental
disorders,
functional
and/or
structural
asymmetries
are
changed
compared
to
healthy
controls,
these
alterations
may
contribute
primary
symptoms
cognitive
impairments
specific
disorder.
Since
multiple
genetic
epigenetic
factors
influence
both
pathogenesis
illness
development
asymmetries,
it
likely
neural
developmental
pathways
overlap
or
even
causally
intertwined,
although
timing,
magnitude,
direction
interactions
vary
depending
on
However,
underlying
steps
neuronal
mechanisms
still
unclear.
this
review
article,
we
briefly
summarise
what
know
about
structural,
functional,
relationships
outline
hypothetical
connections,
which
could
be
investigated
in
appropriate
animal
models.
Altered
cerebral
features
disorder,
as
trigger
neuropathogenesis
embedded
asymmetrical
organisation
developing
brain.
Therefore,
occurrence
severity
processing
cognition
probably
cannot
understood
independently
lateralised
intra-
networks.
Conversely,
impaired
cellular
processes
can
also
hinder
favourable
asymmetry
lead
deficits
particular.
Pharmaceuticals,
Год журнала:
2024,
Номер
17(5), С. 610 - 610
Опубликована: Май 9, 2024
Although
the
dopamine
hypothesis
of
schizophrenia
explains
effects
all
available
antipsychotics
in
clinical
use,
there
is
an
increasing
need
for
developing
new
drugs
treatment
positive,
negative,
and
cognitive
symptoms
chronic
psychoses.
Xanomeline–trospium
(KarXT)
a
drug
combination
that
based
on
essential
role
played
by
acetylcholine
regulation
processes
interactions
between
this
neurotransmitter
other
signaling
pathways
central
nervous
system,
with
potential
onset
schizophrenia,
Alzheimer’s
disease,
substance
use
disorders.
A
systematic
literature
review
included
four
electronic
databases
(PubMed,
Cochrane,
Clarivate/Web
Science,
Google
Scholar)
US
National
Library
Medicine
database
trials
detected
twenty-one
sources
referring
to
fourteen
studies
focused
KarXT,
out
which
only
have
results.
Based
results
these
trials,
short-term
efficacy
tolerability
xanomeline–trospium
are
good,
but
more
data
needed
before
may
be
recommended
use.
However,
theoretical
level,
exploration
KarXT
useful
interest
researchers
finding
new,
non-dopaminergic,
could
used
either
as
monotherapy
or
add-on
drugs.
Development and Psychopathology,
Год журнала:
2024,
Номер
unknown, С. 1 - 11
Опубликована: Фев. 26, 2024
Research
on
serious
mental
disorders,
particularly
psychosis,
has
revealed
highly
variable
symptom
profiles
and
developmental
trajectories
prior
to
illness-onset.
As
Dante
Cicchetti
pointed
out
decades
before
the
term
"transdiagnostic"
was
widely
used,
pathways
psychopathology
emerge
in
a
system
involving
equifinality
multifinality.
Like
most
other
psychological
psychosis
is
associated
with
multiple
domains
of
risk
factors,
both
genetic
environmental,
there
are
many
transdiagnostic
that
can
lead
psychotic
syndromes.
In
this
article,
we
discuss
our
current
understanding
heterogeneity
etiology
its
implications
for
approaches
conceptualizing
research.
We
highlight
need
examining
factors
at
levels
increase
emphasis
as
key
etiologic
subtypes.
This
will
be
increasingly
feasible
now
large,
longitudinal
datasets
becoming
available
researchers
have
access
more
sophisticated
analytic
tools,
such
machine
learning,
which
identify
homogenous
subtypes
ultimate
goal
enhancing
options
treatment
preventive
intervention.
Psychological Medicine,
Год журнала:
2025,
Номер
55
Опубликована: Янв. 1, 2025
Abstract
Background
Previous
studies
identified
clusters
of
first-episode
psychosis
(FEP)
patients
based
on
cognition
and
premorbid
adjustment.
This
study
examined
a
range
socio-environmental
risk
factors
associated
with
FEP,
aiming
a)
to
compare
FEP
community
controls
using
the
Maudsley
Environmental
Risk
Score
for
(ERS),
weighted
sum
following
risks:
paternal
age,
childhood
adversities,
cannabis
use,
ethnic
minority
membership;
b)
explore
putative
differences
in
specific
environmental
distinguishing
within
patient
from
controls.
Methods
A
univariable
general
linear
model
(GLS)
compared
ERS
between
1,263
derived
802
patients,
namely,
low
(n
=
223)
high-cognitive-functioning
205),
intermediate
224)
deteriorating
150),
EU-GEI
study.
multivariable
GLS
by
different
exposures
included
ERS.
Results
The
was
higher
all
controls,
mostly
(
β
=2.8,
95%
CI
2.3
3.4
,
η
2
0.049)
low-cognitive-functioning
cluster
=2.4,
1.9
2.8,
distinguished
them
high-cognitive-functioning.
had
exposure
(mean
difference
0.48,
0.49
0.91)
than
having
identical
IQ,
more
people
an
0.77,
0.24
1.29)
cluster.
Conclusions
High
might
result
cognitive
impairment
lower-than-expected
functioning
individuals
at
onset
psychosis.
Some
patients’
trajectories
involved
that
could
be
modified
tailored
interventions.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 18, 2025
Abstract
Psychiatry
lags
in
adopting
etiological
approaches
to
diagnosis,
prognosis,
and
outcome
prediction
compared
the
rest
of
medicine.
Etiological
factors
such
as
childhood
trauma
(CHT),
substance
use
(SU),
socioeconomic
status
(SES)
significantly
affect
psychotic
disorder
symptoms.
This
study
applied
an
agnostic
clustering
approach
identify
exposome
clusters
“Exposotypes
(ETs)”
examine
their
relationship
with
clinical,
cognitive,
functional
outcomes.
Using
data
from
individuals
disorders
(n=1,350),
controls
(n=623),
we
assessed
between
exposotypes
Four
were
identified:
ET1
characterized
by
high
CHT
SU;
ET2,
CHT;
ET3,
ET4,
low
exposure.
Compared
demonstrated
higher
positive
general
symptoms,
anxiety,
depression,
impulsivity,
mania;
ET2
had
impulsivity;
ET3
better
cognitive
outcomes
lower
negative
Intracranial
volume
was
largest
smallest
ET2.
No
group
differences
schizophrenia
polygenic
risk
scores
found.
The
age
onset
5
years
earlier
than
ET4.
These
findings
provide
insight
into
complex
interplay
trauma,
SU,
well
unique
effects
on
clinical
cognition,
neurobiology,
genetic
risk,
functioning.
Schizophrenia Bulletin,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 20, 2025
Relapsing
after
a
first
episode
of
schizophrenia
(FES)
is
main
predictor
clinical
and
functional
prognosis.
Brain-derived
neurotrophic
factor
(BDNF)
plays
critical
role
in
neuronal
development
plasticity,
its
signaling
may
be
altered
by
successive
relapses.
We
assessed
the
impact
relapse
expression
2
isoforms
BDNF
tropomyosin-related
kinase
B
(TrkB)
receptor
(active
full-length
TrkB-F
inactive
truncated
TrkB-T)
peripheral
blood
mononuclear
cells
from
53
FES
patients
remission
followed
up
for
3
years.
The
group
participants
that
relapsed
(n
=
24)
during
follow-up
presented
significant
decrease
active
compared
to
baseline
(M
100
±
28.13
vs.
M
83.42
33.84,
t
2.5,
P
.02),
with
no
changes
TrkB-T
nor
plasma
levels.
This
also
led
decline
F/T
ratio
1.13
0.38
0.94
0.36,
2.17,
.041).
No
differences
were
found
receptors'
levels
cases
remained
29).
These
results
not
associated
between
groups
terms
pathway
biomarkers,
or
treatment
variables.
findings
highlight
biological
produces
over
systemic
BDNF-TrkB
pathway,
potentially
undermining
crucial
functions.
Identifying
actors
involved
can
help
design
specific
interventions
prevention
improve
prognosis
people
early
stages
schizophrenia.
Neuropsychopharmacology Reports,
Год журнала:
2025,
Номер
45(1)
Опубликована: Фев. 26, 2025
ABSTRACT
One
of
the
challenges
in
diagnosing
psychiatric
disorders
is
that
results
biological
and
neuroscience
research
are
not
reflected
diagnostic
criteria.
Thus,
data‐driven
analyses
incorporating
cross‐disease
perspectives,
regardless
category,
have
recently
been
proposed.
A
clustering
study
based
on
subcortical
volumes
5604
subjects
classified
into
four
brain
biotypes
associated
with
cognitive/social
functioning.
Among
identified
controls
patients
schizophrenia,
bipolar
disorder,
major
depressive
autism
spectrum
other
disorders,
we
further
analyzed
biotype
1
subjects,
those
an
extremely
small
limbic
region,
for
clinical
utility.
We
found
representative
feature
enlarged
lateral
ventricles.
An
ventricle,
defined
by
average
z
‐score
left
right
ventricle
>
3,
had
a
sensitivity
99.1%
specificity
98.1%
discriminating
1.
However,
presence
was
sufficient
to
classify
patient
subgroups,
as
1%
also
Reclassification
ventricles
according
cognitive
impairment
resulted
stratified
subgroup
included
high
proportion
schizophrenia
diagnoses,
electroencephalography
abnormalities,
rare
pathological
genetic
copy
number
variations.
Data‐driven
analysis
neuroimaging
data
revealed
subgroups
impairment.
This
could
be
new
candidate
disorders.
concept
strategy
may
useful
identifying
biologically
future.